Literature DB >> 24878609

Non-tumorigenic epithelial cells secrete MCP-1 and other cytokines that promote cell division in breast cancer cells by activating ERα via PI3K/Akt/mTOR signaling.

Maria Riverso1, Andreas Kortenkamp2, Elisabete Silva3.   

Abstract

Efforts in understanding the role of the microenvironment in the development of breast cancer have focused on tumor-stroma cross-talk, but the possibility that normal epithelial cells might also play a role in tumor progression has received little attention. Here, we show that non-tumorigenic human mammary epithelial cells (MCF10A and HMEC) secrete factors able to enhance the proliferation of estrogen receptor α (ERα) positive breast cancer cells (MCF7 and T47D) and suppress their ability to undergo apoptosis. Conditioned medium (CM) derived from MCF10A and HMEC cells was capable of activating ERα in a hormone-independent way, by phosphorylating ERα on Ser167. Co-exposure with PI3K and mTORC1 inhibitors significantly reduced the ERα Ser167 phosphorylation and suppressed the proliferation-enhancing effects of both 10A-CM and HMEC-CM on MCF7 cells. We show that MCF10A and HMEC secrete numerous cytokines, among them MCP-1, which was one of the most prevalent. MCP-1 was shown to have a role in the effects elicited by the 10A-CM. It activated the ERα by phosphorylating Ser167 via the PI3K/Akt/mTORC1 signaling pathway, an effect which was further confirmed by silencing the MCP-1 receptors, CCR2 and CCR4. To our knowledge, this is the first time MCP-1 has been shown to contribute to ERα signaling activation. These data suggest that normal mammary cells could have the capability of supporting the proliferation of breast cancer cells via paracrine interactions. A better understanding of the role of these cells may be useful for designing strategies for the prevention of tumor progression at early stages.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Estrogen receptor; MCP-1; Tumor microenvironment

Mesh:

Substances:

Year:  2014        PMID: 24878609     DOI: 10.1016/j.biocel.2014.05.023

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  4 in total

1.  CCL2 regulation of MST1-mTOR-STAT1 signaling axis controls BCR signaling and B-cell differentiation.

Authors:  Lu Yang; Na Li; Di Yang; Anwei Chen; Jianlong Tang; Yukai Jing; Danqing Kang; Panpan Jiang; Xin Dai; Li Luo; Qiuyue Chen; Jiang Chang; Ju Liu; Heng Gu; Yanmei Huang; Qianglin Chen; Zhenzhen Li; Yingzi Zhu; Heather Miller; Yan Chen; Liru Qiu; Heng Mei; Yu Hu; Quan Gong; Chaohong Liu
Journal:  Cell Death Differ       Date:  2021-04-20       Impact factor: 12.067

Review 2.  mTOR at the Transmitting and Receiving Ends in Tumor Immunity.

Authors:  Yakir Guri; Thierry M Nordmann; Jason Roszik
Journal:  Front Immunol       Date:  2018-03-27       Impact factor: 7.561

Review 3.  Cytomegalovirus, Macrophages and Breast Cancer.

Authors:  S Pasquereau; F Al Moussawi; W Karam; M Diab Assaf; A Kumar; G Herbein
Journal:  Open Virol J       Date:  2017-03-31

4.  Caffeic Acid Versus Caffeic Acid Phenethyl Ester in the Treatment of Breast Cancer MCF-7 Cells: Migration Rate Inhibition.

Authors:  Agata Kabała-Dzik; Anna Rzepecka-Stojko; Robert Kubina; Robert Dariusz Wojtyczka; Ewa Buszman; Jerzy Stojko
Journal:  Integr Cancer Ther       Date:  2018-09-24       Impact factor: 3.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.